Lipocine (LPCN) Other Operating Expenses (2012 - 2022)
Lipocine's (LPCN) quarterly Other Operating Expenses came in at $250000.0 in Q2 2022, up 106.25% YoY from $121212.1 in Q2 2021, and up 106.25% on a QoQ basis from -$4.0 million in Q2 2021.
Lipocine (LPCN) Other Operating Expenses (2012 - 2022) Analysis & Trends
Lipocine (LPCN) has 8 years of Other Operating Expenses data on file, last reported at $250000.0 in Q2 2022.
- Quarterly Other Operating Expenses rose 106.25% year-over-year to $250000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $250000.0 (up 106.25% YoY) and the FY2022 annual result came in at $250000.0, up 106.25% from the prior year.
- Other Operating Expenses rose to $250000.0 in Q2 2022, from -$4.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $250000.0 in Q2 2022 to a low of -$4.0 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lipocine | 11.15 Mn | -12.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 250,000.00 |
| Jun 30, 2021 | -4.00 Mn |
| Dec 31, 2017 | 70,798.00 |
| Sep 30, 2017 | 65,811.00 |
| Jun 30, 2017 | 50,852.00 |
| Mar 31, 2017 | 48,355.00 |
| Dec 31, 2016 | 48,675.00 |
| Sep 30, 2016 | 50,735.00 |
| Jun 30, 2016 | 55,009.00 |
| Mar 31, 2016 | 61,659.00 |
| Dec 31, 2015 | 62,400.00 |
| Sep 30, 2015 | 61,560.00 |
| Jun 30, 2015 | 31,297.00 |
| Mar 31, 2015 | 18,633.00 |
| Dec 31, 2014 | 20,638.00 |
| Sep 30, 2014 | 24,299.00 |
| Jun 30, 2014 | 37,935.00 |
| Mar 31, 2014 | 25,466.00 |
| Dec 31, 2013 | 22,181.00 |
| Sep 30, 2013 | 15,084.00 |